CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Reconciliation of net income to cash provided by operating activities:
Net income	$ 61,912	$ 57,122
Add (deduct):
Depreciation and amortization	13,748	6,430
Provision for bad debt	14	708
Net realized and unrealized gains	(4,085)	(3,274)
Amortization of net premium on debt securities investments	690	938
Payments for title losses less than provisions	8,959	12,234
Adjustments for insurance recoveries of title losses	220	(205)
Decrease (increase) in receivables – net	6,226	(3,513)
Increase in other assets – net	(5,046)	(7,869)
Decrease in accounts payable and other liabilities – net	(50,808)	(20,116)
Change in net deferred income taxes	265	2,007
Net income from equity method investments	(736)	(924)
Dividends received from equity method investments	1,167	764
Stock-based compensation expense	2,239	3,174
Other – net	110	(34)
Cash provided by operating activities	34,875	47,442
Investing activities:
Proceeds from sales of investments in securities	17,650	3,051
Proceeds from matured investments in debt securities	15,923	42,836
Purchases of investments in securities	(66,882)	(47,881)
Net (purchases) sales of short-term investments	(60)	2,648
Purchases of property and equipment, and real estate	(12,291)	(5,721)
Proceeds from sale of property and equipment and other assets	829	0
Cash paid for acquisition of businesses	(17,904)	(52,575)
Cash paid for acquisition of equity method investment	(69)	(16,080)
Other – net	(2,412)	131
Cash used by investing activities	(65,216)	(73,591)
Financing activities:
Proceeds from notes payable	140	178,975
Payments on notes payable	(37,819)	(154,910)
Distributions to noncontrolling interests	(4,568)	(3,844)
Repurchases of Common Stock	(2,462)	(1,935)
Proceeds from stock option and employee stock purchase plan exercises	2,492	61
Cash dividends paid	(10,119)	(8,840)
Payment of contingent consideration related to acquisitions	(6,262)	0
Purchase of remaining interest in consolidated subsidiaries	0	(2,570)
Other - net	36	(777)
Cash (used) provided by financing activities	(58,562)	6,160
Effects of changes in foreign currency exchange rates	(367)	69
Change in cash and cash equivalents	(89,270)	(19,920)
Cash and cash equivalents at beginning of period	485,919	432,683
Cash and cash equivalents at end of period	$ 396,649	$ 412,763